And it's nothing to do with the fetching red clothing of the version of the new OneXFly F1 Pro I've been testing, either.

The ONEXPLAYER G1 is either a mini-laptop that an also be used as a handheld gaming system, or a gaming handheld that can also be used as a general-purpose laptop. It’s a compact computer with ...

This recently teased OneXPlayer G1 handheld with a removeable keyboard is a good sign of things to come, anyways. We'll be embarking fully into the second generation of handheld tech in 2025 ...

After a couple months of uncertainty, the FDA has told compounding pharmacies that they have 60 to 90 days before the agency will enforce rules to stop their production of GLP-1s. The FDA confirmed on ...

In another nontraditional turn for medication management, recent reports have found that some patients are “microdosing” GLP-1s in unapproved smaller amounts to mitigate side effects and make ...

The Tecno Spark Go 1S was officially announced in the fourth quarter of 2024. The budget smartphone is fueled with a non-removable Li-Ion 5000 mAh battery + 15W wired charging. The phone is available ...

Semaglutide and other GLP-1s have gained widespread popularity as treatments for Type 2 diabetes and obesity, and it doesn’t stop there—they’re currently being tested in a wide variety of ...

Eli Lilly, which has been directing patients to various telehealth sites as it sells its blockbuster obesity medication Zepbound, is broadening its reach, announcing a partnership Wednesday with ...

Although genetics can play a role in penis size, many other factors can also affect penis size, including hormones, nutrition, and diet. Factors such as height and shoe size do not affect or ...

GLP-1s are being studied for cardiovascular disease, liver conditions, kidney disease, and Alzheimer’s. Older approved GLP-1s from Novo Nordisk, Sanofi, and Amylin have been or are being ...

These drugs can also slow gastric emptying, which contributes to weight loss. GLP-1s were first approved by FDA to treat type 2 diabetes, with more recent entrants approved to treat weight loss ...